FdaApplication

BLA 020580

Back to search

Identifiers

Properties

PropertyValue
applicant_nameOrganon USA Inc., a subsidiary of Merck & Co., Inc.
application_typeBLA
approval_date1996-12-09

Products (1)

ProductActive ingredientStrengthDosage form
COTAZYMPANCRELIPASE (AMYLASE; LIPASE; PROTEASE)8,000USP UNITS; 30,000USP UNITS; 30,000USP UNITSCapsule, Delayed Release

1 product